FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:860-862 March 14, 2002 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In the National Emphysema Treatment Trial (NETT) (Oct. 11 issue),¹ the authors report that of the approximately 1000 patients randomly assigned to undergo lung-volume–reduction surgery or to receive medical treatment alone, 140 were identified as being at unusually high risk for death after surgery and were unlikely to benefit from the surgery. Two thirds of the patients in the high-risk group had a radiologic pattern of homogeneous moderate or severe destruction coupled with a severe functional deficit (forced expiratory volume in one second, 20 percent of the predicted value). In our opinion, this group of patients should . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.